Onderneming Larimar Therapeutics, Inc.
Aandelen
LRMR
US5171251003
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,89 USD | +4,24% | +6,66% | +51,43% |
Vakgebied
Aantal werknemers: 42
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 65 | - | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 28-05-20 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-18 |
John Berman
ADM | Chief Administrative Officer | 57 | 01-01-17 |
Compliance Officer | - | 01-12-16 | |
Russell Clayton
CTO | Chief Tech/Sci/R&D Officer | - | 17-07-23 |
Gopi Shankar
PRN | Corporate Officer/Principal | - | 07-02-23 |
Comptroller/Controller/Auditor | - | 01-07-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 28-05-20 |
Frank Thomas
BRD | Director/Board Member | 54 | 28-05-20 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 03-10-23 |
Chief Executive Officer | 65 | - | |
Joseph Truitt
CHM | Chairman | 59 | 28-05-20 |
Thomas Hamilton
BRD | Director/Board Member | 56 | 28-05-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 63 800 017 | 62 942 921 ( 98,66 %) | 0 | 98,66 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,43% | 440 mln. | |
-3,46% | 102 mld. | |
+1,41% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-15,84% | 21,4 mld. | |
-9,16% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-14,65% | 16,09 mld. | |
+4,39% | 13,83 mld. | |
+31,35% | 11,97 mld. |
- Beurs
- Aandelen
- Koers LRMR
- Onderneming Larimar Therapeutics, Inc.